Lilly Oncology President Jacob Van Naarden: A Music-Loving Dealmaker With Clear Vision

Jacob Van Naarden, who now leads Lilly Oncology and heads corporate business development, first gained attention on a Princeton University stage where he performed as a Broadway character during his sophomore year.

His early love of music and theater has shaped a reputation for intensity and focus in negotiating deals for the company. Colleagues describe him as someone who knows exactly what he wants and pursues it with determination.

At Lilly, Van Naarden applies that same drive to advance oncology collaborations, guiding the company’s strategic partnerships and pipeline growth. His unique blend of creative background and business acumen makes him a distinctive figure in the pharma deal‑making landscape.